Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

All SEC Filings

Date Form Description PDF XBRL Pages
06/30/17 8-K Current report filing
Documents
9
06/27/17 8-K Current report filing
Documents
8
06/13/17 8-K Current report filing
Documents
5
05/31/17 8-K Current report filing
Documents
18
05/23/17 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material 7
05/23/17 8-K Current report filing
Documents
8
05/19/17 8-K Current report filing 3
05/16/17 8-K Current report filing
Documents
9
05/12/17 4 Statement of changes in beneficial ownership of securities 2
05/12/17 10-Q Quarterly report pursuant to Section 13 or 15(d) 35
RSS